APRE earnings: real EPS beat/miss history, analyst consensus Buy, P/E -0.38. Updated 2026-07-23.
Aprea Therapeutics (APRE) Research Hub
Aprea Therapeutics (APRE) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 0.7739 USD (-2.21%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.38, market cap 0.00B. This hub links to the full technical, earnings and options research available for APRE.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.7739 USD (-2.21%) |
| 52-week range | 0.5993 USD – 1.16 USD |
| Trend regime | Range |
| 14-day RSI | 58.6 (Bullish) |
| Trailing P/E | -0.38 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
Available research for APRE
Covered Call on APRE: how it works, illustrative setup around the real 0.7739 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on APRE: how it works, illustrative setup around the real 0.7739 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on APRE: how it works, illustrative setup around the real 0.7739 USD price, max profit/loss, breakeven and when to use it. Educational.
APRE technical analysis: range, last 0.7739 USD, RSI 58.6, 52w range 0.5993 USD–1.16 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is APRE in?
Aprea Therapeutics (APRE) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is APRE in an uptrend or downtrend?
As of 2026-09-11, APRE is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is APRE's trailing P/E ratio?
APRE's trailing P/E is -0.38, with a market cap of 0.00B. See the earnings research page for full valuation detail.